NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Pharmesis International Ltd (SGX: P31)

 
P31 Technical Analysis
3
As on 25th Aug 2015 P31 Share Price closed @ 0.04 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.04 & Buy for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

P31 Share Price

Open 0.04 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.04 1 Week 0.00 0.00
Close 0.04 1 Month 0.00 0.00
Volume 2000 1 Year 0.00 0.00
52 Week High 0.79 | 52 Week Low 0.41
 
SGX Singapore Most Active Stocks
N21 131.00 0.00%
A50 0.13 0.00%
5DE 0.02 0.00%
576 0.15 0.00%
EG0 0.03 0.00%
C8R 0.06 0.00%
B22 0.09 0.00%
5ME 0.20 0.00%
E5H 0.40 0.00%
Z74 3.75 0.00%
 
SGX Singapore Top Gainers Stocks
A6F 0.24 2300.00%
C11 0.12 1100.00%
A69 0.09 800.00%
T16 0.19 533.33%
A10 0.04 300.00%
L05 0.04 300.00%
X27 0.08 100.00%
D2V 0.06 100.00%
D2V 0.06 100.00%
L18 0.02 100.00%
 
SGX Singapore Top Losers Stocks
5BM 0.01 -90.91%
P82 0.01 -87.50%
B2X 0.04 -83.33%
B2X 0.04 -83.33%
A54 0.07 -46.15%
F18 0.03 -40.00%
A18 0.09 -35.71%
C37 0.02 -33.33%
Y07 0.03 -25.00%
A02 0.04 -20.00%
 
 
P31
Daily Charts
P31
Intraday Charts
Whats New @
Bazaartrend
P31
Free Analysis
 
P31 Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
SUPPORT0.00
SUPPORT0.00
 
P31 Target for Month September
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
P31 Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
P31 Target for Year 2020
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
P31 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website >
 
P31 Address
P31
No. 8 Yingbin Road
Chengdu,
China
 
P31 Latest News
 
Your Comments and Response on Pharmesis International Ltd
 
P31 Business Profile
Pharmesis International Ltd., an investment holding company, develops, manufactures, and sells western medicines, health tonic products, and traditional Chinese medicine (TCM) formulated products in the People’s Republic of China. The company operates through Western Drugs, TCM Formulated Drugs, and Distribution segments. It is also involved in the wholesale of chemical drugs, biological raw products, TCMs, antibiotics, and antibiotics agents. The company offers its western medicines and TCM formulated products in the form of tablets, granules, pills, etc. Its products comprise Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Xiao Shi Jian Pi tablets for the treatment of flatus, inappetency, dyspepsy, and spleen weakness; and LianPu ShuangQing for the treatment of acute inflammation, such as dysentery and intestinal infection. Pharmesis International Ltd. also offers Shulinghou tablets, which clear heat and regenerate body fluid, as well as for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness; Er Ding granules for the treatment of jaundice, as well as clears heat toxics; and AFenKa for the treatment of migrane, pain, headache, cold, nasosinusitis, muscle pain, menstrual pain, toothache, and arthritis. In addition, the company provides Wuling Jiao Nang granules, which disperse water accumulation, regulate water circulation, and dispel dampness; Bear Bile and Bulbus Fritillariae oral liquid for the treatment of phlegmheat cough; and Gansu for the treatment of acute and chronic hepatitis. Pharmesis International Ltd. markets its western drugs under the Kinna brand name; and TCM formulated drugs under the Longlife brand name to approximately 2,000 hospitals through its sales and marketing personnel. The company was founded in 1996 and is headquartered in Chengdu, the People’s Republic of China.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service